Kampo Japanese Herbal Therapy Clinical Trials

• Herbal Therapy in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028977 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Determining Long-Term Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00412516 - Active, not recruiting
  Encephalitis, Japanese B
  
• Valeriana Officinalis (Valerian) for Improving Sleep in Patients With Cancer Receiving Adjuvant Therapy
  ClinicalTrials.gov Identifier: NCT00075842 - Active, not recruiting
  Sleep Disorders; unspecified adult solid tumor, protocol specific; Fatigue
  
• Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00055718 - Active, not recruiting
  Drug Toxicity; childhood acute lymphoblastic leukemia
  
• Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00088946 - Active, not recruiting
  transitional cell carcinoma of the bladder; stage 0 bladder cancer; stage I bladder cancer
  
• American Ginseng in Treating Patients With Cancer-Related Fatigue
  ClinicalTrials.gov Identifier: NCT00182780 - Active, not recruiting
  Fatigue; unspecified adult solid tumor, protocol specific
  
• Mistletoe in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Are Receiving Palliative Chemotherapy
  ClinicalTrials.gov Identifier: NCT00052325 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Huang Lian (Chinese Herb) in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00014378 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060086 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Live Attenuated Japanese Encephalitis (JE) Vaccine Coadministered With Measles Vaccine in Infants 9 Months of Age
  ClinicalTrials.gov Identifier: NCT00463684 - Recruiting
  Japanese Encephalitis
  
• A Study Designed to Evaluate the Safety and Efficacy of a Combination Herbal Therapy (CHT), Versus Placebo in Patients with Irritable Bowel Syndrome (IBS)
  ClinicalTrials.gov Identifier: NCT00130741 - Completed
  Colonic Diseases, Functional
  
• Boosterability of Live Attenuated Japanese Encephalitis (JE) Vaccine in Children Who Have Previously Received Inactivated JE Vaccine
  ClinicalTrials.gov Identifier: NCT00463476 - Recruiting
  Japanese Encephalitis
  
• Hypericum Perforatum (St. John's wort) in Relieving Hot Flashes in Women With Non-Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00110136 - Recruiting
  Breast Cancer; breast cancer in situ; Hot Flashes
  
• Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00040742 - Recruiting
  nausea and vomiting; unspecified adult solid tumor, protocol specific
  
• Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease
  ClinicalTrials.gov Identifier: NCT00031720 - Recruiting
  Breast Cancer; breast cancer in situ; Hot Flashes
  
• A Long Term Safety and Efficacy Study of Fabrazyme Replacement Therapy in Japanese Patients With Fabry Disease.
  ClinicalTrials.gov Identifier: NCT00233870 - Recruiting
  Fabry Disease
  
• Green Tea Extract in Preventing Esophageal Cancer in Patients With Barrett''s Esophagus
  ClinicalTrials.gov Identifier: NCT00233935 - Recruiting
  Esophageal Cancer; Precancerous Condition
  
• Treatment of Japanese Encephalitis
  ClinicalTrials.gov Identifier: NCT00216268 - Recruiting
  Japanese Encephalitis
  
• Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00028964 - Active, not recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; recurrent breast cancer; Drug Toxicity
  
• An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects
  ClinicalTrials.gov Identifier: NCT00280384 - Active, not recruiting
  Spasmodic Torticollis
  
• Hormone Therapy in Treating Patients With Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003026 - Active, not recruiting
  adenocarcinoma of the prostate
  
• Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles Vaccine
  ClinicalTrials.gov Identifier: NCT00249769 - Completed
  Encephalitis, Japanese B
  
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00049374 - Active, not recruiting
  refractory plasma cell neoplasm
  
• Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma
  ClinicalTrials.gov Identifier: NCT00004024 - Active, not recruiting
  adult brain tumor
  
• Bevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00023959 - Active, not recruiting
  Head and Neck Cancer
  
• Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00006480 - Active, not recruiting
  disseminated neuroblastoma; Drug Toxicity; recurrent neuroblastoma
  
• Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA
  ClinicalTrials.gov Identifier: NCT00418717 - Active, not recruiting
  Arthritis, Rheumatoid
  
• SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00026377 - Active, not recruiting
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate
  
• The Pharmacokinetics Study of Concentrated Herbal Formula and Traditional Herbal Decoctions in Humans
  ClinicalTrials.gov Identifier: NCT00329212 - Completed
  Healthy
  
• Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases
  ClinicalTrials.gov Identifier: NCT00033254 - Active, not recruiting
  brain metastases
  
• Study Evaluating the Pharmacokinetics of HCV-796 in Healthy Japanese Men
  ClinicalTrials.gov Identifier: NCT00385190 - Active, not recruiting
  Healthy
  
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers
  ClinicalTrials.gov Identifier: NCT00421226 - Active, not recruiting
  Healthy
  
• Study to Evaluate Multiple Doses of ERB-041 in Healthy, Female Japanese Subjects
  ClinicalTrials.gov Identifier: NCT00434187 - Active, not recruiting
  Healthy
  
• Safety and Efficacy Study of Budesonide (Pulmicort®) Turbuhaler® in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00509028 - Active, not recruiting
  Asthma
  
• Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00055913 - Active, not recruiting
  Head and Neck Cancer
  
• Vaccine Therapy and/or Sargramostim in Treating Patients With Locally Advanced or Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005034 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00014560 - Active, not recruiting
  Lymphocytic Lymphoma; Non-Hodgkin's Lymphoma
  
• Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma
  ClinicalTrials.gov Identifier: NCT00232648 - Active, not recruiting
  Asthma
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00082823 - Active, not recruiting
  Cancer
  
• Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00083213 - Active, not recruiting
  Cancer
  
• Immunogenicity and Safety of GSK Biologicals' HPV Vaccine 580299 in Healthy Japanese Females 10-15 Years of Age
  ClinicalTrials.gov Identifier: NCT00492544 - Active, not recruiting
  Papillomavirus Infections; Cervical Cancer
  
• Vaccine Therapy With or Without Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00006385 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Fruit and Vegetable Extracts in Treating Patients With Stage I, Stage II, Stage III, Stage IVA, or Stage IVB Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00064298 - Recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Combination Chemotherapy and Filgrastim Followed by Radiation Therapy in Treating Patients With Stage II or Stage IIIA Breast Cancer
  ClinicalTrials.gov Identifier: NCT00007904 - Active, not recruiting
  stage II breast cancer; stage IIIA breast cancer; Male Breast Cancer
  
• Monoclonal Antibody Therapy Plus Sargramostin in Treating Patients With Advanced Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002560 - Active, not recruiting
  recurrent neuroblastoma
  
• Enzastaurin in Treating Patients With Recurrent Gliomas
  ClinicalTrials.gov Identifier: NCT00112788 - Active, not recruiting
  adult brain tumor
  
• Temozolomide and Radiation Therapy With or Without Vatalanib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00128700 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00182689 - Active, not recruiting
  Lung Cancer
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00002786 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Biological Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00045149 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00067015 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer; Quality of Life
  
• Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00096512 - Active, not recruiting
  Head and Neck Cancer
  
• Trastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/neu-Expressing Cancer
  ClinicalTrials.gov Identifier: NCT00084513 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Effect of Herbal Extracts on Gingival Inflammation
  ClinicalTrials.gov Identifier: NCT00554034 - Recruiting
  Gingivitis
  
• Soy Isoflavone Compared With No Treatment Before Surgery in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022269 - No longer recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIC breast cancer
  
• Warfarin and Vatalanib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00091299 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00108732 - Active, not recruiting
  recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00089206 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00028678 - Active, not recruiting
  adult glioblastoma; adult giant cell glioblastoma; adult gliosarcoma
  
• Antihypertensive Efficacy and Safety of Approved Drugs in Japanese Patients with Essential Hypertension (Banyu Study)
  ClinicalTrials.gov Identifier: NCT00092209 - Active, not recruiting
  Hypertension
  
• Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients with Locally Advanced Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00016913 - Active, not recruiting
  adenocarcinoma of the prostate; stage III prostate cancer
  
• Evaulation of Interaction Between Herbal Products and Anticoagulants
  ClinicalTrials.gov Identifier: NCT00071682 - Enrolling by invitation
  control of anticoagulation
  
• Herbal Alternatives for Menopause Symptoms (HALT Study)
  ClinicalTrials.gov Identifier: NCT00169299 - Active, not recruiting
  Vasomotor Symptoms Associated With Menopause
  
• Comparison of Combination Chemotherapy Regimens in Treating Patients With Ewing's Sarcoma or Neuroectodermal Tumor
  ClinicalTrials.gov Identifier: NCT00006734 - Active, not recruiting
  localized tumors of the Ewing's family
  
• Cetuximab, Combination Chemotherapy, and Radiation therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00109850 - Active, not recruiting
  Adenocarcinoma of the Esophagus; squamous cell carcinoma of the esophagus; stage III esophageal cancer
  
• Antineoplaston Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00003456 - Active, not recruiting
  adult glioblastoma
  
• Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00006113 - Active, not recruiting
  stage III melanoma; Stage IV Melanoma; Recurrent Melanoma
  
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00003653 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084708 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma
  ClinicalTrials.gov Identifier: NCT00104884 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Biological Therapy Plus Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00040950 - Active, not recruiting
  adult non-Hodgkin's lymphoma
  
• Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00054522 - Active, not recruiting
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Vaccine Therapy Plus Interleukin-12 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00015977 - Active, not recruiting
  adenocarcinoma of the prostate; stage IV prostate cancer; recurrent prostate cancer
  
• Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00006359 - Active, not recruiting
  adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
  
• Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007826 - Active, not recruiting
  Colon Cancer; Rectal Cancer
  
• Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05)
  ClinicalTrials.gov Identifier: NCT00242307 - Active, not recruiting
  Bronchial Asthma
  
• A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving Methotrexate
  ClinicalTrials.gov Identifier: NCT00345748 - Active, not recruiting
  Rheumatoid Arthritis
  
• A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00445939 - Active, not recruiting
  Crohn's Disease
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Sorafenib in Treating Patients with Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00119249 - Active, not recruiting
  Stage IV Melanoma
  
• GW786034 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00005959 - Active, not recruiting
  Lymphoma
  
• Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00089219 - Active, not recruiting
  intraocular melanoma; Melanoma
  
• Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089115 - Active, not recruiting
  grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma
  
• Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia
  ClinicalTrials.gov Identifier: NCT00399464 - Active, not recruiting
  Prostatic Hyperplasia
  
• Combination Chemotherapy in Treating Women With Stage I Breast Cancer
  ClinicalTrials.gov Identifier: NCT00055679 - Active, not recruiting
  stage I breast cancer
  
• Brief Strategic Family Therapy for Adolescent Drug Abusers - 1
  ClinicalTrials.gov Identifier: NCT00095303 - Active, not recruiting
  Behavior Therapy
  
• Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx
  ClinicalTrials.gov Identifier: NCT00004227 - Active, not recruiting
  Oral Cancer; Throat Cancer
  
• Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female Subjects
  ClinicalTrials.gov Identifier: NCT00458107 - Completed
  Schizophrenia
  
• Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
  ClinicalTrials.gov Identifier: NCT00381849 - Recruiting
  Cystinuria; Calcium Nephrolithiasis
  
• Epoetin alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00060398 - Active, not recruiting
  recurrent prostate cancer; Anemia; Fatigue
  
• Celecoxib in Treating Patients With Early-Stage Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00058006 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Long-Term Study of Safety and Efficacy of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 71 y) (APTA-2217-07)
  ClinicalTrials.gov Identifier: NCT00246922 - Active, not recruiting
  Bronchial Asthma
  
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005044 - Active, not recruiting
  adenocarcinoma of the prostate; stage II prostate cancer; stage III prostate cancer
  
• Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
  ClinicalTrials.gov Identifier: NCT00217620 - Active, not recruiting
  adult soft tissue sarcoma
  
• Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas
  ClinicalTrials.gov Identifier: NCT00003113 - Active, not recruiting
  Lymphoma
  
• Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00098475 - Active, not recruiting
  stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma
  
• PEG-Interferon alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00090870 - Active, not recruiting
  Stage IV Renal Cell Cancer
  
• Sorafenib With or Without Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00126594 - Active, not recruiting
  renal clear cell carcinoma; Stage IV Renal Cell Cancer
  
• Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00053768 - Active, not recruiting
  adult non-Hodgkin's lymphoma